Diabetic retinopathy is a common diabetic eye diseasewhich is caused due to some changes in the blood vessels of the retina. The retina is a light-sensitive tissue that is present is the eye and ...

Vantage Biosciences has dosed the first subject in the randomised Phase II trial of oral therapy VX-01 to treat ...

The global Diabetic Retinopathy Market is valued at USD 9.1 Billion in 2024 and is projected to reach a value of USD 15.1 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 6.5% between 2025 ...